Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 2,486 | 985 | 25 | 0 |
| Gross Profit | 2,486 | 985 | 25 | N/A |
| Operating Expenses | 7,838 | 7,537 | 6,113 | 0 |
| Operating Income | -5,352 | -6,552 | -6,088 | N/A |
| Interest Expense | 30 | 996 | 1,354 | 0 |
| Other Income | 698 | 3,922 | -342 | 0 |
| Pre-tax Income | -4,684 | -3,626 | -7,784 | 0 |
| Net Income Continuous | -4,684 | -3,626 | -7,784 | N/A |
| Net Income | $-4,684 | $-3,626 | $-7,784 | $N/A |
| EPS Basic Total Ops | -71.20 | -61.35 | -131.70 | N/A |
| EPS Basic Continuous Ops | -71.21 | -61.46 | -131.71 | N/A |
| EPS Diluted Total Ops | -71.20 | -61.35 | -131.70 | N/A |
| EPS Diluted Continuous Ops | -71.21 | -61.46 | -131.71 | N/A |
| EBITDA(a) | $-5,284 | $-6,501 | $-6,045 | $N/A |